Clinuvel Pharmaceuticals Stock Forecast

Buy or Hold candidate since Jun 26, 2026 Gain 3.43%

The Clinuvel Pharmaceuticals Ltd. stock price gained 0.691% on the last trading day (Monday, 13th Jul 2026), rising from $7.24 to $7.29. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.80% from a day low at $7.29 to a day high of $7.64. The price has risen in 6 of the last 10 days and is up by 3.43% over the past 2 weeks. Volume fell on the last day by -704 shares and in total, 38 shares were bought and sold for approximately $277.02 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $7.51 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 7.95% during the next 3 months and, with a 90% probability hold a price between $6.89 and $8.11 at the end of this 3-month period.

CLVLY Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Monday, June 22, 2026, and so far it has fallen -0.95%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. The Clinuvel Pharmaceuticals Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $7.21 and $6.88. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Clinuvel Pharmaceuticals Ltd. stock

Clinuvel Pharmaceuticals Ltd. finds support from accumulated volume at $6.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.350 between high and low, or 4.80%. For the last week the stock has had daily average volatility of 1.56%.

Our recommended stop-loss: $7.02 (-3.67%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (CLVLY) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Clinuvel Pharmaceuticals Ltd. to open at $7.41, and during the day (based on 14 day Average True Range), to move between $7.16 and $7.42, which gives a possible trading interval of +/-$0.255 (+/-3.56%) up or down from last closing price. If Clinuvel Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 3.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $7.30 (0.14%) than the support at $6.94 (4.80%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Clinuvel Pharmaceuticals Ltd. stock A Buy?

Clinuvel Pharmaceuticals Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.781 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $7.41 ( 1.60%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk